Market Place
Sourcing Support
All News #Library
Others
Turn Therapeutics Reports Year 2025 Financial Results & Updates
31 Mar 2026 //
BUSINESSWIRE
Turn Therapeutics Secures $25M Financing From Avenue Capital
24 Mar 2026 //
PHARMIWEB
Turn Therapeutics Appoints Dr. Robert Redfield As Senior Advisor
17 Feb 2026 //
BUSINESSWIRE
Turn Therapeutics Reports Q3 2025 Financial Results
13 Nov 2025 //
GLOBENEWSWIRE
Turn Therapeutics Initiates Webinar Series For Shareholder
20 Oct 2025 //
GLOBENEWSWIRE
Turn Therapeutic Validate 100% VSV Recovery from Petrolatum Carrier
02 May 2025 //
BUSINESSWIRE
Turn Therapeutics` AD Candidate Shows Promising Cytokine Inhibition
05 Aug 2024 //
PR NEWSWIRE
Turn`s Atopic Dermatitis Candidate Reduces Disease Severity by 57% In-Vivo
20 Jun 2024 //
BUSINESSWIRE
Turn Therapeutics Invites Investment For Wound, Eczema, Toenail Formulas
22 May 2024 //
BUSINESSWIRE
MIMEDX Announces Wound Surgical Product Pipeline Expansion Agreement with Turn
08 Dec 2022 //
GLOBENEWSWIRE
Turn Therapeutics Announces Trial Data for COVID-19 Early Intervention Candidate
25 Aug 2021 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.